Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis

被引:0
|
作者
Fangfang Chen
Yitian Lang
Shikai Geng
Xiaodong Wang
Liangjing Lu
Shuang Ye
Le Zhang
Ting Li
机构
[1] Ren Ji Hospital,Department of Rheumatology
[2] Shanghai Jiaotong University School of Medicine,Department of Pharmacy
[3] Ren Ji Hospital,Department of Pharmacy
[4] Shanghai Jiaotong University School of Medicine,undefined
[5] Huangpu Branch,undefined
[6] Shanghai Ninth People’s Hospital,undefined
[7] Shanghai Jiaotong University School of Medicine,undefined
来源
Clinical Rheumatology | 2023年 / 42卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2923 / 2923
相关论文
共 50 条
  • [1] The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
    Fangfang Chen
    Yitian Lang
    Shikai Geng
    Xiaodong Wang
    Liangjing Lu
    Shuang Ye
    Le Zhang
    Ting Li
    Clinical Rheumatology, 2023, 42 : 2777 - 2786
  • [2] The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis (Jul, 10.1007/s10067-023-06659-9, 2023)
    Chen, Fangfang
    Lang, Yitian
    Geng, Shikai
    Wang, Xiaodong
    Lu, Liangjing
    Ye, Shuang
    Zhang, Le
    Li, Ting
    CLINICAL RHEUMATOLOGY, 2023, 42 (10) : 2923 - 2923
  • [3] COST EFFECTIVENESS ANALYSIS OF UPADACITINIB AND METHOTREXATE FOR PATIENTS WITH METHOTREXATE-RESISTANT RHEUMATOID ARTHRITIS
    Jadhav, S.
    Yang, Y.
    VALUE IN HEALTH, 2020, 23 : S217 - S217
  • [4] Successful treatment with etanercept in a case of seronegative rheumatoid arthritis with corticosteroid/methotrexate-resistant pemphigus erythematosus
    Ohkubo, Naoaki
    Nakano, Kazuhisa
    Miyagawa, Ippei
    Iwata, Shigeru
    Fukuyo, Shunsuke
    Kubo, Satoshi
    Tamaki, Yasutaro
    Nakayamada, Shingo
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY CASE REPORTS, 2018, 2 (02) : 137 - 142
  • [5] Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial
    Kremer, Joel M.
    Genant, Harry K.
    Moreland, Larry W.
    Russell, Anthony S.
    Emery, Paul
    Abud-Mendoza, Carlos
    Szechinski, Jacek
    Li, Tracy
    Ge, Zhiyu
    Becker, Jean-Claude
    Westhovens, Rene
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) : 865 - 876
  • [6] A cost effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.
    Choi, HK
    Seeger, J
    Weinstein, M
    Kuntz, K
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S387 - S387
  • [7] The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis
    Kume, Kensuke
    Amano, Kanzo
    Yamada, Susumu
    Kanazawa, Toshikatsu
    Ohta, Hiroyuki
    Hatta, Kazuhiko
    Amano, Kuniki
    Kuwaba, Noriko
    RHEUMATOLOGY, 2014, 53 (05) : 900 - 903
  • [8] A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis
    Choi, HK
    Seeger, JD
    Kuntz, KM
    ARTHRITIS AND RHEUMATISM, 2000, 43 (10): : 2316 - 2327
  • [9] The Effect of Tofacitinib on Bone Mineral Density in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
    Kume, Kensuke
    Amano, Kanzo
    Yamada, Susumu
    Kanazawa, Toshikatsu
    Hatta, Kazuhiko
    Kuwaba, Noriko
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] THE EFFECT OF TOCILIZUMAB ON BONE MINERAL DENSITY IN PATIENTS WITH METHOTREXATE-RESISTANT ACTIVE RHEUMATOID ARTHRITIS
    Kume, K.
    Amano, K.
    Yamada, S.
    Kanazawa, T.
    Ohta, H.
    Hatta, K.
    Amano, K.
    Kuwaba, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 950 - 950